Onasemnogene abeparvovec
4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Onasemnogene abeparvovec for bulbo-spinal atrophy, x-linked | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Onasemnogene abeparvovec for muscular atrophy | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Onasemnogene abeparvovec for muscular atrophy, spinal | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Onasemnogene abeparvovec for spinal muscular atrophies of childhood | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |